The European Congress of Radiology (ECR) is not only the largest and most important medical imaging conference in Europe, it is also the official annual meeting of ESHIᴹᵀ.
There will be a large variety of sessions and scientific presentations on hybrid, molecular and translational imaging and, as such, we highly recommend to join the congress.
Thursday, March 12, 2020
11:00 – 12:00
Austria Center Vienna, Room M6
How can we differentiate reactive changes from residual neoplasia in post-operative PET/CT?
Following the invitation of Dr. Sikandar Shaikh, our hybrid imaging ambassador to India, ESHI co-organised a joint session at the annual conference of the Indian Radiology & Imaging Association (IRIA) 2020.
It is now possible to renew your membership for the year 2020. If you are not a member yet, we would be happy to welcome you to the society. Application is quick and easy, plus the fee is only 10€ or FREE!!
In the name of ESHIᴹᵀ, I wish you all an enjoyable and relaxing holiday season and all the best for a successful 2020.
You asked for it and we deliver.
We received so many interesting questions during the live broadcast of CHILI that our faculty did not manage to answer all of them during the dedicated discussions. This is why our expert faculty took the time to go through all of the questions from the chat and answer the most relevant/most frequent ones.
CHILI: Statistics, behind the scenes and a survey
Case: Neurolymphomatosis detected by 18F-FDG PET/CT
Webinar: PET/CT in infection and inflammation – Nov 20
Site Visit Video: PETSCAN ViennaPaper: Validated imaging biomarkers as decision-making tools
Webinar: Perfusion imaging: An update on clinical applications and relevance – Nov 27
News: Quality control tests for PET/MRI vary widely in Europe
Quality control tests for PET/MRI vary widely in Europe By Wayne Forrest, AuntMinnieEurope.com staff writer A survey of eight large European imaging facilities with extensive clinical experience of PET/MRI has found wide variations in daily quality control and...
A paper on validated imaging biomarkers as decision-making tools in clinical trials and routine practice was published with the involvement of the ESHI research committee in Insights into Imaging.